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Abstract In this work the susceptibility of mobile and
cystic forms of Borrelia burgdorferi to hydroxychloroq-
uine (HCQ) was studied. The minimal bactericidal
concentration (MBC) of HCQ against the mobile spi-
rochetes was >32 lg/ml at 37 C, and >128 lg/ml at
30 C. Incubation with HCQ signiﬁcantly reduced the
conversion of mobile spirochetes to cystic forms. When
incubated at 37 C, the MBC for young biologically
active cysts (1-day old) was >8 lg/ml, but it was
> 32 lg/ml for old cysts (1-week old). Acridine orange
staining, dark-ﬁeld microscopy and transmission elec-
tron microscopy revealed that the contents of the cysts
were partly degraded when the concentration of HCQ
was ‡MBC. At high concentrations of HCQ (256 lg/ml)
about 95% of the cysts were ruptured. When the con-
centration of HCQ was ‡MBC, core structures did not
develop inside the cysts, and the amount of RNA in
these cysts decreased signiﬁcantly. Spirochetal structures
inside the cysts dissolved in the presence of high con-
centrations of HCQ. When the concentration of HCQ
was ‡MBC, the core structures inside the cysts were
eliminated. These observations may be valuable in the
treatment of resistant infections caused by B. burgdor-
feri, and suggest that a combination of HCQ and a
macrolide antibiotic could eradicate both cystic and
mobile forms of B. burgdorferi.
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Introduction
Borrelia burgdorferi sensu lato, the causative bacterium
of Lyme borreliosis, has been divided into at least ten
genospecies, but the multisystem infection is usually
caused by the three genospecies of Borrelia burgdorferi:
B. garinii, B. afzelii, and B. burgdorferi sensu stricto [51].
A conclusive diagnosis of Lyme borreliosis may be dif-
ﬁcult to achieve since the symptoms are complex and
may resemble those of many other diseases. Serology,
PCR, and cultivation are important tools to make the
conclusive diagnosis of Lyme borreliosis, but all these
techniques have their shortcomings, and false-positive or
false-negative results are frequent [4, 11, 18, 19, 35, 44,
46,47]. B. burgdorferi has the ability to adopt cystic
forms both in vivo and in vitro, e.g. when exposed to
antibiotics commonly used for treating Lyme borreliosis
[12, 21, 23, 30, 40,43]. This phenomenon, combined with
the ability of the cysts to reconvert to normal mobile
spirochetes [1, 5–7], may explain a reactivation of the
disease after an illusory cure– and not a ‘‘post-Lyme
syndrome’’ as postulated by other researchers. This hy-
pothesis requires susceptibility testing of the cystic forms
to antibiotics capable of penetrating the cyst wall, and
then eradicating the biologically active structures inside
the cyst. B. burgdorferi has a very heterogeneous ap-
pearance and may be problematic to cure, especially if
the infection has lasted for some time [25, 26, 32–34, 37,
39,41]. Since B. burgdorferi has the ability to convert to
cystic forms both in vivo and in vitro [1, 6, 7, 12, 21, 23,
30, 40,43], this may partly explain the diﬃculties in the
treatment of this infection.
We recently demonstrated that the cystic forms are
susceptible to metronidazole [8], but because of the
heterogeneity of the bacteria, some strains might be re-
sistant to this agent. Therefore, we propose that antibi-
otics which are used against protozoa could be of value
against cystic forms of B. burgdorferi. Malaria infections
are treated with hydroxychloroquine (HCQ). The non-
protonated form of chloroquine can permeate the cell
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membrane and then be protonated in the acidic envi-
ronment of the vesicle. More polar molecules are unable
to diﬀuse out of the vesicle [14]. These high concentra-
tions of HCQ inside the cell are able to inhibit RNA and
DNA synthesis [14,45]. The purpose of this study was to
examine if in vivo concentrations of HCQ may have any
eﬀect against both cystic and mobile forms of B. burg-
dorferi.
Materials and methods
The bacterial strain used was Borrelia burgdorferi ACA-1 (origi-
nally isolated in Sweden by Eva A˚sbrink, Karolinska Institute,
So¨dersjukhuset, Department of Dermatology, Stockholm,
Sweden).
Production of spirochetes
A sample (0.1 ml) of a bacterial culture in exponential growth was
transferred to 4 ml BSK-H medium (Sigma B3528) [39]. The con-
centration of inactivated (56 C, 30 min) rabbit serum (Sigma
R7136) in the BSK-H medium was 6%, and this serum was tested
to be free of antibodies against B. burgdorferi by the manufacturing
company (Sigma, St. Louis, Mo., USA). All culture media were
sterile-ﬁltered using a 0.2-lm ﬁlter, ensuring both sterility and the
absence of mammalian cells from serum. All cultures were incu-
bated in sterile 5-ml closed tubes (Nalgene cryovial; Nalge, Roth-
erwa, UK) at 30 C.
Production of cystic forms
After 1 week of cultivation the tube was centrifuged (3,200 g,
30 min). The sediment and 0.5 ml of the supernatant were mixed
(2·108 mobile spirochetes/ml, and no cysts were observed at that
moment). This mixture of sediment and supernatant was diluted
1:100 in distilled water at 4 C. The concentration of bacteria in the
distilled water was 2·106 bacteria/ml. One part of the culture was
incubated for 24 h and the other for 7 days, both at 30 C. The
number of cysts in the water culture was examined by dark-ﬁeld
microscopy (DFM) (400· and 800·) (Zeiss Axiophot; Carl Zeiss,
Oberkochen, Germany). The number of spirochetes or cysts was in
all cases determined by observation of 10-ll samples by DFM
(200–400·).
Susceptibility testing with hydroxychloroquine
Plaquenil (HCQ; 200 mg) (Sanoﬁ Winthrop, UK) was dissolved in
distilled water, sterile-ﬁltered using a 0.2-lm ﬁlter, and diluted
geometrically in 5-ml Nalgene tubes from 512 lg/ml to 1.0 lg/ml in
2 ml of diluted BSK-H medium (dilution 1:100 in distilled water).
The control consisted of a tube containing only diluted BSK-H. A
2-ml suspension of cystic forms at the age of 24 h and 7 days was
added to each of the HCQ dilutions and to the control tube in a
ﬁnal concentration ranging from 0.5–256 lg/ml.
Susceptibility testing for HCQ was performed for mobile spi-
rochetes in a ﬁnal dilution of 0.5–256 lg/ml in non-diluted BSK-H
medium. The ﬁnal volume was 4 ml in each tube; 40 ll of 107
bacteria in exponential growth was added. Dilutions of HCQ in
0.9% NaCl were additionally made to exclude any inhibiting eﬀect
of BSK-H medium on the antibiotic. To examine if HCQ could
prevent the conversion of normal mobile spirochetes to cystic
forms, susceptibility testing was also carried out in distilled water.
Incubation conditions for susceptibility testing
Susceptibility testing for the cysts was carried out for 1-day-old and
7-day-old cysts. The 1-day-old cysts were incubated at 30 C for 2
and 4 weeks, and at 37 C for 2 weeks. The 7-day-old cysts were
incubated at 30 C for 4 weeks. The mobile bacteria were incu-
bated in BSK-H medium at 37 C for 2 weeks and at 30 C for
4 weeks; in 0.9% NaCl at 30 C for 2 weeks, and in distilled water
at 30 C for 2 weeks.
Examination of the hydroxychloroquine-exposed microbes
The tubes with the mobile borreliae in BSK-H medium were ex-
amined by DFM (200–800·) 2 or 4 weeks after addition of HCQ to
detect the presence of mobile spirochetes. The mobile bacteria in
0.9% NaCl were examined similarly 1 and 2 weeks after addition of
HCQ, and the mobile bacteria in distilled water were examined
after 3 h and 2 weeks. A 0.1-ml suspension of these non-mobile
spirochetes was transferred to fresh BSK-H medium and incubated
for 2 months, and subcultured every second week.
The tubes containing cysts were examined by DFM (200· and
800·), and the number of intact cysts was counted. Twenty ll of
the culture was transferred to a glass slide, dried, ﬂame-ﬁxed and
overlaid with 50 mg/l acridine orange (AO) in phosphate buﬀer,
pH 6.4, for 4 min, and ﬁnally rinsed in distilled water. The AO-
stained cysts were examined by UV-microscopy (1,000–2,000·).
HCQ-exposed cysts at 30 C and 37 C were vitally stained by
mixing 10 ll AO (100 mg/l in phosphate buﬀer, pH 7.4) and 10 ll
of culture on a glass slide protected with a coverslip. The vitally
stained cysts were examined by UV-microscopy (400–2000·).
Reconversion of cystic forms to spirochetal forms
A 0.3 ml sample of each HCQ dilution in distilled water (con-
taining 106 cysts/ml) was transferred to 4 ml BSK-H medium (re-
sulting in 8·104 cysts/ml) and incubated at 30 C in tightly capped
tubes. The tubes were centrifuged (3,200 g, 30 min), and the sedi-
ment was mixed with 0.5 ml of the supernatant and examined by
DFM. A magniﬁcation of 200· was used for the overview, and the
formation of spirochetes from the cysts was examined at 800·.
Four ml fresh BSK-H medium was added to each tube to examine
whether the cysts could convert totally or partly to normal borr-
eliae. This process was repeated every 1–2 weeks and was stopped
after 2 months.
To examine whether any normal mobile spirochetes were
present in the water culture at the time of the transfer to BSK-H
medium, a method previously described [5,6] was used: the water
culture (control) was ﬁltered using a 0.45-lm ﬁlter (Schleicher and
Schuell FP 030/2; Dassel, Germany). A 0.3 ml aliquot of the ﬁl-
trate was transferred to 4.0 ml BSK-H medium, cultured for
2 months and examined. If normal mobile spirochetes are present,
even at extremely low concentrations, they will pass through the
ﬁlter [22].
Electron microscopy
The following cultures were examined by transmission electron
microscopy (TEM): cysts from HCQ-free controls, cysts from
cultures with 8, 32, and 64 lg/ml HCQ in distilled water incubated
at 37 C for 14 days. The examination by TEM was carried out
according to the following procedure. The cultures were centri-
fuged (5,000 g, 20 min), the medium was removed and replaced
with 2% glutaraldehyde in 0.2 M cacodylate buﬀer (pH 7.3), and
the bacteria were ﬁxed for 2 h. The bacteria were post-ﬁxed in 1%
osmium tetroxide in 0.2 M cacodylate buﬀer for 2 h. The pellets
were dehydrated, inﬁltrated and embedded in conventional epoxy
resin (LX-112; Ladd, Burlington, Vt., USA) by a method described
earlier [9,10]. Ultrathin sections were cut with a diamond knife
(Jumdi; Juniper ultra Micro, Stockholm, Sweden) on an ultrami-
crotome (LKB 2088 Ultrotom V) and mounted on 200-mesh cop-
per grids. The sections were stained with 5% uranyl acetate in 30%
ethanol for 20 min and Reynolds lead citrate for 5 min and then
examined in a Jeol 1200 EX electron microscope to identify
bacterial structures.
26
Results
Susceptibility testing for cystic forms
Rupturing was observed in 20–95% of the 1-day-old
cysts that had been incubated in HCQ dilutions of
8–256 lg/ml at 30 C for 14 days (most rupturing for
the highest concentrations). The same results were
obtained when 7-day-old cysts were incubated at 30 C
for 4 weeks. After incubation at 37 C for 14 days,
similar rupturing results occurred, but in the range of
4–256 lg/ml HCQ. In AO-stained ﬁxed smears of cysts,
the control cysts (without HCQ incubation) were a
bright orange-red color. These cysts contained distinct
spirochetal structures. Following incubation for 4 or
2 weeks, 30–40% and 10–20% of the cysts contained
core structures, respectively (Fig. 1A, B). At 8 lg HCQ/
ml (37 C) and 16–32 lg HCQ /ml (30 C), less than
5% of the cysts contained core structures, and the con-
tents of the cysts were dissolved and had a weak green
color (Fig. 2A, B). Staining with AO revealed initial
disruption of the internal structures and a color change
from orange to green even at an HCQ concentration of
4 lg/ml. When spirochetes were incubated in distilled
water at an HCQ concentration of 64 lg/ml for 1 week,
some spirochetes resembled streptococci when the cysts
were stained with AO (Fig. 3). The contents of the cysts
seemed to dissolve completely at an HCQ concentration
of 32 lg/ml at 37 C. The blebs showed a pycnotic
appearance (Fig. 4).
When cysts that had been incubated at 37 C for
14 days or at 30 C for 4 weeks were vitally stained with
AO, the cores were bright green when the concentration
of HCQ was 4 lg/ml, and both orange and green at an
HCQ concentration of 8 lg/ml. All core structures
stained red and the membrane was very thin or disrupted
at an HCQ concentration ‡16 lg/ml (Fig. 5 A, B, C).
When the cysts were incubated at 30 C for 14 days,
they were green at an HCQ concentration of 8 lg/ml,
green/orange at 16 lg/ml and orange at 32 lg/ml. When
7-day-old cystic forms were incubated for 4 weeks, they
were green at an HCQ concentration of 16 lg/ml, green/
orange at 32 lg/ml and orange at 64 lg/ml.
Reemergence of mobile spirochetes from cysts
When transferred to BSK-H medium, 10–20% of the
cysts converted to immobile spirochetes for control
cysts, or cysts which had been exposed to a low con-
centration of HCQ. The converted spirochetes were
relatively short, but a few of them(1–5%) had a normal
appearance, except for being very thin. No further de-
velopment was observed beyond 1 month of incubation
(Fig. 6). When the concentration of HCQ was above the
MBC, no beginning spirochetes were seen protruding
from the cysts. Only a few blebs (tubuli) were observed,
and these looked pycnotic (see Fig. 4).
Susceptibility testing for mobile spirochetes
Susceptibility testing of normal mobile borreliae showed
that the MBC to HCQ was >32 lg/ml if the incubating
temperature was 37 C for 14 days, >128 lg/ml if the
temperature was 30 C for 2 weeks, and >32 lg/ml
when the temperature was 30 C for 4 weeks. Only a few
cystic forms originated from mobile spirochetes in the
BSK-H media at HCQ=MBC. In these cysts, mostly
small granula were visible along the degenerated spiro-
chetes (Fig. 7). Susceptibility testing in 0.9% NaCl at
30 C for 14 days resulted in a MBC of >128 lg/ml.
There was an equal number of cystic structures in the
HCQ-free control tube as in the tubes containing
concentrations of HCQ<MBC.
Fig. 1A, B. Cystic forms of
Borrelia burgdorferi incubated
for 14 days in distilled water
without hydroxychloroquine
(HCQ). A At 30 C, Distinct
bacterial structures and cores
are observed inside the cysts.
The intensely stained bacteria
and cores indicate signiﬁcant
amounts of RNA. The cysts
were ﬂame-ﬁxed and stained
with acridine orange. Bar 3 lm.
B At 37 C. Distinct spirochetal
and core structures are
observed inside the cysts.
TEM (uranyl acetate and lead
citrate). Bar 500 nm
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The eﬀect of hydroxychloroquine on the conversion
of mobile spirochetes to cysts
Susceptibility testing for mobile spirochetes in distilled
water resulted in a rate of conversion that was strongly
dependent on the HCQ concentration and the incuba-
tion time. After incubation at 30 C for 3 h, the
number of converted spirochetes ranged from none at
an HCQ concentration of 256 lg/ml, 10% at 128 lg/
ml, 30% at 64 lg/ml, 50% at 8–32 lg/ml, and 80% at
2–4 lg/ml. At HCQ concentrations of 0.5 and 1.0 lg/
ml, and in the HCQ-free control, more than 95% of
spirochetes had converted to normal cysts in 3 h.
About 5% of free spirochetes started to show
degradation at an HCQ concentration of 4 lg/ml, with
increasing rates at higher HCQ concentrations. The
content of the cysts showed initial granulation at 32 lg
HCQ/ml. After a 2-week incubation, cysts from the
2–256 lg HCQ/ml tubes appeared pycnotic with
respect to contents, and looked like small granula. No
distinct bacteria or core structures were visible inside
the cysts, in contrast to the 1.0 and 0.5 lg/ml concen-
trations and the HCQ-free control. A few degraded
spirochetes could be observed even at a concentration
of 2 lg/ml. AO staining (pH 6.4) of cysts exposed to an
HCQ concentration of 2 lg/ml were slightly green. The
contents of the cysts dissolved if HCQ concentration
was ‡2 lg/ml.
Fig. 2A, B. Cystic forms of
B. burgdorferi incubated for
14 days. A At 30 C in distilled
water with 16 lg HCQ/ml, the
cysts are diﬀuse and no distinct
bacteria or cores are observed;
only pycnotic bacteria are pre-
sent. The staining is weak,
which illustrates low concen-
tration of RNA. The cysts were
ﬂame-ﬁxed and stained with
acridine orange. Bar 3 lm. B At
37 C and 8 lg HCQ/ml, most
of the cysts are intact but the
intracystic spirochetal forms are
completely dissolved into small
granula. Even the core struc-
tures show initial disruption.
TEM (uranyl acetate and lead
citrate). Bar 500 nm
Fig. 3. Spirochetes incubated in distilled water at 37 C for 1 week
with 64 lg HCQ/ml. The intracystic spirochetes appears as small
granula, and the intensely stained RNA is only partly present,
which makes the spirochetes resemble streptococci. The cysts were
ﬂame-ﬁxed and stained with acridine orange. Bar 3 lm
Fig. 4. Cystic forms of B. burgdorferi incubated at 37 C for
14 days in distilled water with 32 lg HCQ/ml. The cysts have less
contents than following incubation in 8 lg HCQ/ml. TEM (uranyl
acetate and lead citrate). Bar 500 lm
28
Discussion
Our results show that HCQ alone may be suﬃcient in
the treatment of intracellular cystic forms of borreliae,
since cystic forms are susceptible to this agent at con-
centrations which are achievable in vivo intracellularly
at normal body temperature [45]. However, when the
infection is located at the dermis, and when free-living
B. burgdorferi circulate in the bloodstream, the MBC of
HCQ is not achievable. Susceptibility testing for the
mobile spirochetes in 0.9% NaCl resulted in the same
MBC as obtained for susceptibility testing in BSK-H
medium, which means no inhibitory eﬀect of MSB-H
medium to HCQ.
The susceptibility testing of B. burgdorferi to HCQ in
distilled water revealed a signiﬁcant decrease in the
formation of cysts within the ﬁrst 3 h, but 14 days later
no normal spirochetes could be observed. The content of
the cysts rapidly degraded, but the rate of degradation
increased over time. Therefore, it is possible that HCQ
has some rapid inhibitory eﬀect on the development of
cystic forms in vitro, e.g. alkaline degradation [6,24], not
involving inhibition of RNA and DNA. Further de-
gradation of the spirochetes and the cystic contents may
account for the direct inhibition of DNA and RNA. The
contents of the blebs is of great pathogenic importance
[28], and these structures were pycnotic at HCQ con-
centrations achievable in vivo.
The orange color of AO-stained ﬁxed cysts (pH 6.4)
diminished with increasing concentrations of HCQ. This
indicates little or no RNA synthesis, and thereby little or
no biological activity. At the highest HCQ concentra-
tion, most of the cysts ruptured, and even when the
concentration of HCQ was <MBC, some of them had
Fig. 5A–C. Susceptibility testing of 1-day-old cystic forms of
B. burgdorferi to HCQ in distilled water at 37 C for 14 days.
Vital AO staining, pH 7.4. A At an HCQ concentration of 4 lg/ml,
the cyst contains green cores (living organisms). B At an HCQ
concentration of 8 lg/ml, the cyst contains both green and orange
cores. C At an HCQ concentration of 16 lg/ml, the cyst has a
diﬀuse membrane and contains red-orange core/granula (biologi-
cally inactive organisms). Bar 3 lm
Fig. 7. Susceptibility testing of mobile B. burgdorferi in BSK-H
medium at 30 C for 14 days at 256 lg HCQ/ml. Mainly small
granula are visible among the pycnotic spirochetes. Dark-ﬁeld
microscopy. Bar 6 lm
Fig. 6. B. burgdorferi cysts were incubated at 30 C for 14 days in
distilled water with 16 lg HCQ/ml and then transferred to BSK-H
medium. After incubation for 4 weeks in BSK-H medium, some
thin immobile spirochetes protrude from the cysts. Dark-ﬁeld
microscopy. Bar 6 lm
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ruptured and were degraded. This means that cysts are
aﬀected even at HCQ concentrations lower than the
estimated MBC.
However, vital AO staining (pH 7.4) of HCQ-incu-
bated cysts in distilled water revealed the formation of
immobile spirochetes. Additionally, the amount of cystic
RNA, and also TEM observation argues for the esti-
mated MBC. Living organisms stain bright green, while
those that are non-viable stain orange and red. The
shifts in AO staining from bright green to orange/red
means increasing uptake of AO caused by intercalation
of the stain with the phosphate-sugar backbone of DNA
as the DNA becomes denatured in non-viable cells
[27,31].
An important feature is the temperature-dependent
inﬂuence of HCQ on mobile bacteria and cysts. At
30 C, higher amounts of HCQ are required to destroy
the cysts than at 37 C. This is in agreement with the
results obtained with other antibiotics [8,42] and may be
signiﬁcant when cysts are located in the dermis. In a
previous report of susceptibility testing of normal mo-
bile B. burgdorferi to HCQ, the MBCs ranged from 50 to
90 lg/ml for diﬀerent strains; there was no information,
however, about the incubation temperature [13].
The conversion of cysts to mobile spirochetes de-
pends strongly on the composition of the culture medi-
um [1,5–8], and the quality of the rabbit serum is
especially important. We have recently shown that old
cystic forms are diﬃcult to transform into mobile spi-
rochetes [5,6]. We were not able to obtain mobile spi-
rochetes, but thin immobile spirochetes developed from
the core structures of the cysts incubated in
HCQ<MBC.
Increased pH in the vesicle may be advantageous for
intracellular bacteria, because O2– is absent, but since
B. burgdorferi produces superoxide dismutase, the bac-
terium is protected from the disadvantageous acidic
environment as well [52]. Since macrolides are also more
active in an alkaline environment, a combination ther-
apy with HCQ and a macrolide seems advantageous
[15]. B. burgdorferi is considered to be a facultative
intracellular organism and animal cells may shelter the
spirochete [17, 20, 21, 29, 30, 36,51]; therefore, it seems
sensible to use an agent like HCQ, which can concen-
trate inside the cells.
We have established that mobile and cystic forms of
B. burgdorferi are susceptible to HCQ in vitro in a time-,
temperature- and concentration-dependent manner. As
far as we know, this is the ﬁrst susceptibility testing of
cystic forms of B. burgdorferi to HCQ. We did not use
metabolites of HCQ in this study, although these com-
pounds could theoretically be more eﬀective than the
parent drug. Since the MBC values for HCQ obtained in
this study are achievable intracellularly in vivo [45], and
because the eﬀect of the drug is mainly anti-cystic, HCQ
may be useful in treating Lyme borreliosis. In addition,
HCQ is a safe antibiotic with important anti-inﬂam-
matory activity suitable for the treatment of chronic
Lyme disease [2, 16, 45,49].
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